| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.49▼ | 2.49▼ | 2.49▼ | 2.56▼ | 2.47▲ |
| MA10 | 2.50▼ | 2.55▼ | 2.55▼ | 2.49▲ | 2.49▲ |
| MA20 | 2.55▼ | 2.51▼ | 2.51▼ | 2.44▲ | 2.76▼ |
| MA50 | 2.42▲ | 2.41▲ | 2.41▲ | 2.54▼ | 3.35▼ |
| MA100 | 2.44▲ | 2.43▲ | 2.41▲ | 2.81▼ | 7.00▼ |
| MA200 | 2.51▼ | 2.70▼ | 2.86▼ | 3.16▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.016▼ | -0.016▼ | 0.024▲ | 0.042▲ |
| RSI | 46.956▼ | 48.051▼ | 47.772▼ | 50.994▲ | 44.712▼ |
| STOCH | 16.477▼ | 9.722▼ | 9.722▼ | 77.117 | 26.030 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -30.986 | -89.616▼ |
| CCI | -103.384▼ | -115.352▼ | -115.352▼ | 58.520 | -35.174 |
|
Tuesday, April 29, 2025 05:00 AM
Two studies report favorable clinical outcomes and safety data for Renuvion® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin Rapid weight loss due ...
|
|
Sunday, April 27, 2025 05:00 PM
Spartan Capital successfully served as the sole placement agent for Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) in a $3.788 million private placement. This financing represents an important miles ...
|
|
Wednesday, April 23, 2025 05:42 AM
Lipella Pharmaceuticals Inc. announced that its abstract on LP-10, a liposomal tacrolimus oral rinse for treating Oral Lichen Planus (OLP), will be presented by Dr. Alessandro Villa at the 2025 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 2.56 | 2.56 | 2.50 | 2.52 | 6,766 |
| 30/04/25 | 2.50 | 2.557 | 2.4418 | 2.49 | 4,885 |
| 29/04/25 | 2.55 | 2.55 | 2.50 | 2.50 | 7,681 |
| 28/04/25 | 2.66 | 2.66 | 2.58 | 2.635 | 15,149 |
| 25/04/25 | 2.54 | 2.74 | 2.54 | 2.65 | 68,587 |
| 24/04/25 | 2.355 | 2.58 | 2.25 | 2.58 | 55,348 |
| 23/04/25 | 2.49 | 2.49 | 2.2601 | 2.41 | 77,304 |
| 22/04/25 | 2.26 | 2.44 | 2.03 | 2.395 | 2,735,300 |
| 21/04/25 | 2.25 | 2.43 | 2.25 | 2.28 | 4,400 |
| 17/04/25 | 2.271 | 2.44 | 2.271 | 2.40 | 7,000 |
|
|
||||
|
|
||||
|
|